Methamphetamine use and schizophrenia: A population-based cohort study in California

American Journal of Psychiatry

Volumn 169, Issue 4, 2012, Pages 389-396

  Callaghan, Russell C ^a,b,c,d   Cunningham, James K ^a,b,c,d   Allebeck, Peter ^a,b,c,d   Arenovich, Tamara ^a,b,c,d   Sajeev, Gautam ^a,b,c,d   Remington, Gary ^a,b,c,d   Boileau, Isabelle ^a,b,c,d   Kish, Stephen J ^a,b,c,d  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CANNABIS; COCAINE; METHAMPHETAMINE; OPIATE;

ADULT; ALCOHOLISM; APPENDICITIS; ARTICLE; CANNABIS ADDICTION; COCAINE DEPENDENCE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG ABUSE; DRUG DEPENDENCE; FEMALE; HAZARD RATIO; HUMAN; MAJOR CLINICAL STUDY; MALE; OPIATE ADDICTION; OUTCOME ASSESSMENT; POPULATION RESEARCH; PRIORITY JOURNAL; SCHIZOPHRENIA; SENSITIVITY ANALYSIS; UNITED STATES;

EID: 84860276920     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2011.10070937     Document Type: Article

References (38)

1. Minozzi S: An overview of systematic reviews on cannabis and psychosis: discussing apparently conflicting results. Drug Alcohol Rev 2010; 29:304-317
2. Zorick TS, Rad D, Rim C, Tsuang J: An overview of methamphetamine- induced psychotic syndromes. Addict Disord Their Treat 2008; 7:143-156
3. Sato M, Numachi Y, Hamamura T: Relapse of paranoid psychotic state in methamphetamine model of schizophrenia. Schizophr Bull 1992; 18:115-122
4. Angrist B: Amphetamine psychosis: clinical variations of the syndrome, in Amphetamine and Its Analogs: Pharmacology, Toxicology, and Abuse. Edited by Cho AK, Segal DS. New York, Academic Press, 1994, pp 387-411
5. Grelotti DJ, Kanayama G, Pope HG Jr: Remission of persistent methamphetamine-induced psychosis after electroconvulsive therapy: presentation of a case and review of the literature. Am J Psychiatry 2010; 167:17-23
6. Flaum M, Schultz SK: When does amphetamine-induced psychosis become schizophrenia? Am J Psychiatry 1996; 153:812-815 (Pubitemid 26170544)
7. van Winkel R, Stefanis NC, Myin-Germeys I: Psychosocial stress and psychosis: a review of the neurobiological mechanisms and the evidence for gene-stress interaction. Schizophr Bull 2008; 34:1095-1105
8. Zach A: New Way to Edit: Discharge Data Review. Sacramento, California Office of Statewide Health Planning and Development, 1990
9. California Office of Statewide Health Planning and Development: Editing Criteria Handbook. Sacramento, 1995
10. California Office of Statewide Health Planning and Development: Report of the Results From OSHPD Reabstracting Project: An Evaluation of the Reliability of Selected Patient Discharge Data, July Through December 1988. Sacramento, 1990
11. Rawson NS, Malcolm E, D'Arcy C: Reliability of the recording of schizophrenia and depressive disorder in the Saskatchewan health care datafiles. Soc Psychiatry Psychiatr Epidemiol 1997; 32:191-199 (Pubitemid 27258651)
12. Schwartz AH, Perlman BB, Paris M, Schmidt K, Thornton JC: Psychiatric diagnoses as reported to Medicaid and as recorded in patient charts. Am J Public Health 1980; 70:406-408 (Pubitemid 10135409)
13. Kashner TM: Agreement between administrative files and written medical records: a case of the Department of Veterans Affairs. Med Care 1998; 36:1324-1336
14. Hale DA, Molloy M, Pearl RH, Schutt DC, Jaques DP: Appendectomy: a contemporary appraisal. Ann Surg 1997; 225:252-261 (Pubitemid 27131560)
15. Sauerland S, Lefering R, Neugebauer EA: Laparoscopic versus open surgery for suspected appendicitis. Cochrane Database Syst Rev 2004; 4:CD001546
16. Callaghan RC, Cunningham JK, Sajeev G, Kish SJ: Incidence of Parkinson's disease among hospital patients with methamphetamine- use disorders. Mov Disord 2010; 25:2333-2339
17. Lin HC, Hsiao FH, Pfeiffer S, Hwang YT, Lee HC: An increased risk of stroke among young schizophrenia patients. Schizophr Res 2008; 101:234-241
18. McGrath J, Saha S, Welham J, El Saadi O, MacCauley C, Chant D: A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status, and methodology. BMC Med 2004; 2:13
19. US Department of Health and Human Services, Substance Abuse and Mental Health Data Archive: Treatment Episode Data Set: Admissions (TEDS-A), concatenated, 1992 to 2008 (computer file ICPSR25221-v2.2011)
20. Cunningham JK, Liu LM: Impacts of federal ephedrine and pseudoephedrine regulations on methamphetamine-related hospital admissions. Addiction 2003; 98:1229-1237 (Pubitemid 37082816)
21. D'Agostino RB Jr, D'Agostino RB Sr: Estimating treatment effects using observational data. JAMA 2007; 297:314-316
22. D'Agostino RB: Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998; 17:2265-2281
23. Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40:373-383 (Pubitemid 17055592)
24. Austin PC, Mamdani MM: A comparison of propensity score methods: a case-study estimating the effectiveness of post-AMI statin use. Stat Med 2006; 25:2084-2106 (Pubitemid 43950281)
25. Austin PC: Propensity-score matching in the cardiovascular surgery literature from 2004 to 2006: a systematic review and suggestions for improvement. J Thorac Cardiovasc Surg 2007; 134:1128-1135
26. Shah BR, Laupacis A, Hux JE, Austin PC: Propensity score methods gave similar results to traditional regression modeling in observational studies: a systematic review. J Clin Epidemiol 2005; 58:550-559 (Pubitemid 40692720)
27. Macleod J, Oakes R, Oppenkowski T, Stokes-Lampard H, Copello A, Crome I, Smith GD, Egger M, Hickman M, Judd A: How strong is the evidence that illicit drug use by young people is an important cause of psychological or social harm? methodological and policy implications of a systematic review of longitudinal, general population studies. Drugs Educ Prevent Policy 2004; 11:281-297 (Pubitemid 39203289)
28. Zammit S, Allebeck P, Andreasson S, Lundberg I, Lewis G: Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study. BMJ 2002; 325:1199
29. Ujike H, Sato M: Clinical features of sensitization to methamphetamine observed in patients with methamphetamine dependence and psychosis. Ann NY Acad Sci 2004; 1025:279-287 (Pubitemid 39643873)
30. Konuma K: Use and abuse of amphetamines in Japan, in Amphetamine and Its Analogs: Pharmacology, Toxicology, and Abuse. Edited by Cho AK, Segal DS. New York, Academic Press, 1994, pp 415-435
31. Sturmer T, Joshi M, Glynn RJ, Avorn J, Rothman KJ, Schneeweiss S: A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods. J Clin Epidemiol 2006; 59:437-447
32. Jansson LB, Parnas J: Competing definitions of schizophrenia: what can be learned from polydiagnostic studies? Schizophr Bull 2007; 33:1178-1200 (Pubitemid 47351232)
33. Thompson JW, Pincus H: A crosswalk from DSM-III-R to ICD-9- CM. Am J Psychiatry 1989; 146:1315-1319
34. Lieberman JA, Sheitman BB, Kinon BJ: Neurochemical sensitization in the pathophysiology of schizophrenia: deficits and dysfunction in neuronal regulation and plasticity. Neuropsychopharmacology 1997; 17:205-229 (Pubitemid 27440642)
35. Welch KA, McIntosh AM, Job DE, Whalley HC, Moorhead TW, Hall J, Owens DG, Lawrie SM, Johnstone EC: The impact of substance use on brain structure in people at high risk of developing schizophrenia. Schizophr Bull 2011; 37:1066-1076
36. van Os J, Rutten BP, Poulton R: Gene-environment interactions in schizophrenia: review of epidemiological findings and future directions. Schizophr Bull 2008; 34:1066-1082
37. National Institute for Clinical Excellence (NICE): Schizophrenia: Core Interventions in the Treatment and Management of Schizophrenia in Adults in Primary and Secondary Care. London, NICE, 2009
38. Rounsaville BJ: DSM-V research agenda: substance abuse/psychosis comorbidity. Schizophr Bull 2007; 33:947-952